Sanofi Consumer Healthcare India (NSE:SANOFICONR) Inventories, Raw Materials & Components: ₹0 Mil (As of Mar. 2026)


NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
21 GF Score
Price ₹4,566.70
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India Inventories, Raw Materials & Components?

Sanofi Consumer Healthcare India NSE:SANOFICONR +1.34% 21 Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Sanofi Consumer Healthcare India's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0 Mil.

Sanofi Consumer Healthcare India's quarterly raw materials increased from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹358 Mil) but then declined from Dec. 2025 (₹358 Mil) to Mar. 2026 (₹0 Mil).

Sanofi Consumer Healthcare India's annual raw materials declined from Dec. 2023 (₹547 Mil) to Dec. 2024 (₹156 Mil) but then increased from Dec. 2024 (₹156 Mil) to Dec. 2025 (₹358 Mil).


Sanofi Consumer Healthcare India Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Inventories, Raw Materials & Components Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
547.00 156.00 358.00

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 358.00 0.00
NSE:SANOFICONR
21GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0 Mil mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Inventories, Raw Materials & Components of ₹0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Sanofi Consumer Healthcare India and its competitors.
Is Sanofi Consumer Healthcare India's Inventories, Raw Materials & Components too high?
Sanofi Consumer Healthcare India's current Inventories, Raw Materials & Components is ₹0 Mil. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Inventories, Raw Materials & Components compare to LLY and JNJ?
Sanofi Consumer Healthcare India's Inventories, Raw Materials & Components of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sanofi Consumer Healthcare India and its competitors. Sanofi Consumer Healthcare India's current Inventories, Raw Materials & Components is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Inventories, Raw Materials & Components of ₹0 Mil. The current Inventories, Raw Materials & Components is ₹0 Mil. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score

Get the complete analysis for NSE:SANOFICONR

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,566.70
Price